Biotechnology innovation requires the right people, the right tools, and the right capital. ElevateBio’s disruptive, capital efficient business model ensures that Biotechnology innovators have the greatest likelihood of success right from the start. Contained within a state-of-the-art cGMP viral vector manufacturing facility, ElevateBio develops the technology and process expertise that will lead to decades of biotechnology innovation and cutting-edge therapeutics.

As ElevateBio continues its meteoric growth powered by an all-star leadership team, top industry talent, and a diverse group of institutional investors, it will require an innovative approach to building an omnichannel brand, sophisticated digital platforms, and a digital strategy that keeps pace with its growth.

The pace of progress within biotech is immense and teams of researchers exploring potential therapies can coalesce around a new breakthrough, moving from research team to fully operational potential therapeutic companies in months. These teams are often ill-equipped for operating successfully in a digital context – talent marketing, digital marketing, brand strategy, and digital application development are must-haves that can slow the pace of growth within these high-potential businesses.

Our relationship goes beyond strategic and advisory – moving into execution and delivering transformative employee and client experiences, technology, messaging, and brand development. Our team is an extension of ElevateBio, ensuring we can speak to investor, talent, scientific and technical audiences accurately and effectively.

The results speak for themselves: launching multiple digital marketing platforms per year, developing new brands quarterly, and rapidly growing ElevateBio’s audience in key messaging platforms like Twitter and LinkedIn. Agency 39A has powered ElevateBio’s audience growth, talent acquisition, and digital marketing capabilities, helping our partner extend its visionary message.